PDF herunterladen
Fortschr Neurol Psychiatr 2005; 73(5): 286-299
DOI: 10.1055/s-2004-830057
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Ataxien

AtaxiaT.  Weiland1 , K.  Wessel1
  • 1Neurologische Klinik des Klinikums Braunschweig und Forschungsgesellschaft für Kognitive Neurologie, Institut an der Technischen Universität Braunschweig
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
09. Mai 2005 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Lernziele

Nach Studium dieses Artikels sollte der Lesende einen Überblick bekommen über die Klassifikation der Ataxien in erbliche, nicht-erbliche (degenerative, idiopathische und sporadische Formen) sowie symptomatische Formen. Grundzüge von Klinik, Diagnostik, Genetik und (meist nur symptomatischer) Therapie sollen vermittelt werden.

Literatur

  • 1 Abele M, Bürk K, Schöls L, Schwartz S, Besenthal I, Dichgans J. et al . The etiology of sporadic adult-onset ataxia.  Brain. 2002;  125 961-968
    CrossrefPubMedGoogle Scholar
  • 2 Baloh R W, Jen J C. Episodic Ataxia Type 2 and Spinocerebellar Ataxia Type 6.  In: Klockgether T. Handbook of ataxia disorders. New York: Dekker 2000: 447-467
    Google Scholar
  • 3 Barbot C. et al . Recessive ataxia with ocular apraxia: review of 22 Portuguese patients.  Arch Neurol. 2001;  58 201-205
    CrossrefPubMedGoogle Scholar
  • 4 Ben Hamida M, Belal S, Sirugo G. et al . Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families.  Neurology. 1993;  43 2179-2183
    CrossrefPubMedGoogle Scholar
  • 5 Boel M, Casaer P. Familial periodic ataxia responsive to flunarizine.  Neuropediatrics. 1988;  19 218-220
    PubMedGoogle Scholar
  • 6 Botez M I, Botez-Marquard T, Elie R, Pedraza O L, Goyette K, Lalonde R. Amantadine hydrochloride treatment in heredodegenerative ataxias: A double blind study.  J Neurol Neurosurg Psychiatry. 1996;  61 259-264
    PubMedGoogle Scholar
  • 7 Bouchard J P. et al . Autosomal recessive spastic ataxia Charlevoix-Saguenay.  Neuromusc Disord. 1998;  8 474-479
    PubMedGoogle Scholar
  • 8 Butterworth R F. Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.  Metab Brain Dis. 1995;  10 1-8
    PubMedGoogle Scholar
  • 9 Dürr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C. et al . Clinical and genetic abnormalities in patients with Friedreich's ataxia.  N Engl J Med. 1996;  335 1169-1175
    CrossrefPubMedGoogle Scholar
  • 10 Filla A, De Michele G, Marconi R, Bucci L, Carillo C, Castellano A E. et al . Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy.  J Neurol. 1992;  239 351-353
    PubMedGoogle Scholar
  • 11 Gilman S, Low P A, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C J. et al . Consensus statement on the diagnosis of multiple system atrophy.  J Auton Nerv Syst. 1998;  74 189-192
    PubMedGoogle Scholar
  • 12 Griggs R C, Moxley R T, Lafrance R A, McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide.  Neurology. 1978;  28 1259-1264
    CrossrefPubMedGoogle Scholar
  • 13 Hadjivassiliou M, Boscolo S, Davies-Jones G, Grünewald R, Not T, Sanders D. et al . The humoral response in the pathogenesis of gluten ataxia.  Neurology. 2002;  58 1221-1226
    PubMedGoogle Scholar
  • 14 Hadjivassiliou M, Grünewald R, Sharrack B, Sanders D, Lobo A, Williamson C. et al . Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics.  Brain. 2003;  126 685-691
    CrossrefPubMedGoogle Scholar
  • 15 Hausse A O, Aggoun Y, Bonnet D, Sidi D, Munnich A, Rotig A, Rustin P. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.  Heart. 2002;  87 346-349
    CrossrefPubMedGoogle Scholar
  • 16 Jen J C, Yeu Q, Karrim J, Nelson S F, Baloh R W. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide-responsive episodic ataxia.  J Neurol Neurosurg Psychiatry. 1998;  65 565-568
    CrossrefPubMedGoogle Scholar
  • 17 Klockgether T, Wüllner U, Spauschus A, Evert B. The molecular biology of the autosomal-dominant cerebellar ataxias.  Mov Disord. 2000;  15 604-612
    CrossrefPubMedGoogle Scholar
  • 18 Klockgether T, Döller G, Wüllner U, Petersen D, Dichgans J. Cerebellar encephalitis in adults.  J Neurol. 1993;  240 17-20
    PubMedGoogle Scholar
  • 19 Klockgether T. Ataxien. In: Diener HC. Leitlinien für Diagnostik und Therapie in der Neurologie, 2. Auflage. Stuttgart: Thieme 2003: 89-95
    Google Scholar
  • 20 Klockgether T. Erbliche und nicht erbliche Ataxien.  In: Brandt T, Dichgans J, Diener HC. Therapie und Verlauf neurologischer Erkrankungen. 4. Auflage. Kohlhammer 2003: 1027-1039
    Google Scholar
  • 21 Kohlschuetter A. Abetalipoproteinämie.  In: Klockgether T. Handbook of ataxia disorders. New York: Dekker 2000: 205-221
    Google Scholar
  • 22 Koskinen T, Santavuori P, Sainio K. et al . Infantile onset spinocerebellar ataxia with sensory neuropathy - a new inherited disease.  J Neurol Sci. 1994;  121 50-56
    CrossrefPubMedGoogle Scholar
  • 23 LeBer I, Moreira M C, Rivaud-Péchoux S, Chamayou C, Ochsner F, Kuntzer T. et al . Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies.  Brain. 2003;  126 2761-2772
    CrossrefPubMedGoogle Scholar
  • 24 Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz S P, Dann E J. et al . Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.  J Clin Invest. 1993;  91 2488-2496
    PubMedGoogle Scholar
  • 25 Leone M, Bottachi E, Dálessandro G. et al . Hereditary ataxias and paraplegias in Valle d'Aosta, Italy: a study of prevalence and disability.  Acta Neurol Scand. 1995;  91 183-187
    PubMedGoogle Scholar
  • 26 Lou J S, Goldfarb L, McShane L, Gatev P, Hallett M. Use of buspirone for treatment of cerebellar ataxia - An open-label study.  Arch neurol. 1995;  52 982-988
    PubMedGoogle Scholar
  • 27 Martinello F, Fardin P, Ottina M, Ricchieri G L, Koenig M, Cavalier L, Trevisan C P. Supplemental therapy in isolated vitamin E deficiency improves the peripheral neuropathy and prevents the progression of ataxia.  J Neurol Sci. 1998;  156 177-179
    CrossrefPubMedGoogle Scholar
  • 28 Moreira M C, Barbot C, Tachi N, Kozuka N, Uchida E, Gibson T. et al . The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin.  Nat Genet. 2001;  29 189-193
    CrossrefPubMedGoogle Scholar
  • 29 Nitschke M F, Hahn C, Melchert U H, Handels H, Wessel K. Activation of the cerebellum by sensory finger stimulation and by finger opposition movements: A functional magnetic resonance imaging study.  J Neuroimaging. 1998;  8 127-131
    PubMedGoogle Scholar
  • 30 Nitschke M F, Kleinschmidt A, Wessel K, Frahm J. Somatotopic organization of the human anterior cerebellum as detected by functional magnetic resonance neuroimaging.  Brain. 1996;  119 1023-1029
    PubMedGoogle Scholar
  • 31 Nystuen A, Benke P J, Merren J, Stone E M, Sheffield V C. A cerebellar ataxia identified by DNA pooling to search for linkage disequilibrium in an isolated population from the Cayman Islands.  Hum Mol Genet. 1996;  5 525-531
    CrossrefPubMedGoogle Scholar
  • 32 Ouahchi K, Arita M, Kayden H. et al . Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein.  Nature Genet. 1995;  9 141-145
    CrossrefPubMedGoogle Scholar
  • 33 Peynet J, Laurent A, de Liege P, Lecoz P, Gambert P, Legrand A. et al . Cerebrotendinous xanthomatosis: treatment with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.  Neurology. 1991;  41 434-436
    PubMedGoogle Scholar
  • 34 Polo J M, Calleja J, Combarros O, Berciano J. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological study.  Brain. 1991;  114 85-866
    PubMedGoogle Scholar
  • 35 Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D. et al . Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.  Nature Genet. 1997;  7 25-217
    PubMedGoogle Scholar
  • 36 Schöls L, Rieß O. Spinozerebelläre Erkrankungen. Sowie: Autosomal-rezessiv und x-chromosomal vererbte Ataxien.  In: Rieß O, Schöls L. Neurogenetik, 2. Auflage. Kohlhammer Verlag 2002: 367 - 385 sowie-398 - 407
    Google Scholar
  • 37 Schrag A, Ben Shlomo Y, Quinn N P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.  Lancet. 1999;  354 1771-1775
    CrossrefPubMedGoogle Scholar
  • 38 Schulz J B, Dehmer T, Schöls L, Mende H, Hardt C, Vorgerd M. et al . Oxidative stress in patients with Friedreich ataxia.  Neurology. 2000;  55 1719-1721
    CrossrefPubMedGoogle Scholar
  • 39 Trouillas P, Serratrice G, Laplane D, Rascol A, Augustin P, Barroche G. et al . Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia: Results of a double-blind drug-placebo cooperative study.  Arch Neurol. 1995;  52 456-460
    PubMedGoogle Scholar
  • 40 Trouillas P, Xie J, Adeleine P, Michel D, Vighetto A, Honnorat J. et al . Buspirone, a 5-hydroxytryptamine 1a agonist, is active in cerebellar ataxia - Results of a double-blind drug-placebo study in patients with cerebellar cortical atrophy.  Arch Neurol. 1997;  54 749-752
    PubMedGoogle Scholar
  • 41 Warrenburg B P van de, Sinke R J, Verschuuren-Bemelmans C C, Scheffer H, Brunt E R, Ippel P F. et al . Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis.  Neurology. 2002;  58 702-708
    PubMedGoogle Scholar
  • 42 Wenning G K, Ben Shlomo Y, Magalhaes M, Daniel S E, Quinn N P. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.  Brain. 1994;  117 835-845
    CrossrefPubMedGoogle Scholar
  • 43 Wessel K, Schroth G, Diener H C, Müller-Forell W, Dichgans J. Significance of MRI-confirmed atrophy of the cervical cord in Friedreich's ataxia.  Eur Arch Psychiatr Neurol Sci. 1989;  238 225-230
    CrossrefPubMedGoogle Scholar
  • 44 Wessel K, Hermsdörfer J, Deger K, Herzog Th, Huss G P, Kömpf D, Mai N, Schimrigk K, Wittkämper A, Ziegler W. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.  Arch Neurol. 1995;  52 451-455
    PubMedGoogle Scholar
  • 45 Wessel K. Degenerative Ataxien.  In: Berlit P. Klinische Neurologie. Springer 1999: 934-945
    Google Scholar
  • 46 Yabe I, Sasaki H, Yamashita I, Takei A, Tashiro K. Clinical trial of acetazolamide in SCA6, with assessment using the ataxia rating scale and body stabilometry.  Acta Neurol Scand. 2001;  104 44-47
    CrossrefPubMedGoogle Scholar
  • 47 Yokota T, Shiojiri T, Gotoda T. et al . Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the α-tocopherol transfer protein gene.  Ann Neurol. 1997;  41 826-832
    CrossrefPubMedGoogle Scholar

Dr. med. T. Weiland
Prof. Dr. med. K. Wessel

Neurologische Klinik des Klinikums Braunschweig und
Forschungsgesellschaft für Kognitive Neurologie,
Institut an der Technischen Universität Braunschweig

Salzdahlumer Straße 90

38126 Braunschweig

eMail: t.weiland@klinikum-braunschweig.de; k.wessel@klinikum-braunschweig.de